MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-UK-06-0002925
Apple Formulations Private Limited. - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹111.56 Cr
▲ 3% YoY
Net profit · FY 2025
₹2.76 Cr
Net margin 2.5%
EBITDA · FY 2025
₹6.91 Cr
EBITDA margin 6.2%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹22.64 Lakh
Issued & subscribed
Open charges
₹20 Cr
Satisfied ₹9.56 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
80
Provident fund records
About Apple Formulations Private Limited.
Data last updated:
Apple Formulations Private Limited. is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 May 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24121DL2006PTC148648. Its GSTIN is 05AAFCA7557E1ZR (Uttarakhand). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹22.64 Lakh. It is led by directors including Rahul Khaitan and Naveen Khaitan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 24 – C 2nd Floor Pocket – B Sector – G Mayur Vihar – III, Delhi, India – 110096.
As per the financials filed for FY 2025, the company reported a revenue of ₹111.56 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹2.76 Cr (net margin 2.5%) and EBITDA of ₹6.91 Cr (EBITDA margin 6.2%). Revenue has grown at a compounded annual rate (CAGR) of 379% over three years and 12% over five years.
The company has about 80 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Apple Formulations. As per MCA filings, the company has open charges of ₹20 Cr and satisfied charges of ₹9.56 Cr on record. Court records list 46 cases involving the company, including 20 filed by the company and 26 filed against it; 29 cases are pending.
Apple Formulations Private Limited. is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0002925). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website appleformulations.com.
Company details
CIN U24121DL2006PTC148648
Registration Number 148648
Incorporation Date 06 May 2006
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-UK-06-0002925
Recognitions & Rankings of Apple Formulations Private Limited
Contact details
Apple Formulations Private Limited.'s registered office is in Delhi, Delhi. Its website is appleformulations.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat No. 24 – C 2nd Floor Pocket – B Sector – G Mayur Vihar – III, Delhi, India – 110096
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Apple Formulations Private Limited., buy the company report.
Comprehensive company report
Apple Formulations Private Limited. - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Apple Formulations Private Limited operates one associated brand: Apple Formulations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in contract manufacturing of pharmaceutical formulations for clients. | appleformulations.com |
Business activity
The main business activity of Apple Formulations Private Limited is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Apple Formulations Private Limited., buy the company report.
Financials of Apple Formulations Private Limited.
FY 2025 filings availableApple Formulations Private Limited. reported revenue of ₹111.56 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹111.56 Cr ▲ 3%
Net profit · FY 2025
₹2.76 Cr margin 2.5%
EBITDA · FY 2025
₹6.91 Cr margin 6.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 379%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 431%
5 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 3% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.91 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.76 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Apple Formulations Private Limited., buy the company report.
Board of directors of Apple Formulations Private Limited.
Apple Formulations Private Limited has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Khaitan Also directs: Khaitan Wellmax LLP, Viva Packaging Private Limited, Franklin Healthcare Private Limited and 1 more | Director | 03 Jul 2006 | 20 Years 4 Months | Current |
| Naveen Khaitan Also directs: Khaitan Wellmax LLP, Viva Packaging Private Limited, Franklin Healthcare Private Limited and 1 more | Director | 06 May 2006 | 20 Years 5 Months | Current |
| Binod Kumar Jha | Director | 09 Jan 2019 | 7 Years 9 Months | Current |
| Ram Darash Dwivedi | Director | 08 May 2023 | 3 Years 5 Months | Current |
Peer comparison
Apple Formulations Private Limited. is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Socomed Pharma Private Limited | ₹113.64 Cr (FY 2025) | -20.0% | Mumbai, Maharashtra, India | |||
| Seagull Pharmaceuticals Pvt Ltd | ₹113.36 Cr (FY 2025) | 8.0% | Naraina Vihar, Delhi, India | |||
| Stadmed Pvt Ltd | ₹112.88 Cr (FY 2025) | 0.0% | Kolkata, West Bengal, India | |||
| Shree Ganesh Remedies Limited | ₹112.33 Cr (FY 2025) | -13.0% | Anklesvar, Gujarat, India | |||
| Unicure Remedies Private Limited | ₹112.25 Cr (FY 2025) | -13.0% | Vadodara, Gujarat, India | |||
| Apple Formulations Private Limited.this company | ₹111.56 Cr (FY 2025) | ₹2.76 Cr | 2.5% | 3.0% | 80 | Delhi, India |
| Penang Enterprises Private Limited | ₹111.42 Cr (FY 2025) | 21.0% | Mumbai, Maharashtra, India | |||
| Horizon Bioceuticals Pvt Ltd | ₹110.37 Cr (FY 2025) | -9.0% | Panipat, Haryana, India | |||
| Inventaa Industries Private Limited | ₹109.72 Cr (FY 2025) | -17.0% | Kanchikacherla, Andhra Pradesh, India |
To see the full peer comparison of Apple Formulations Private Limited., buy the company report.
Auditor
Apple Formulations Private Limited. is audited by S AGARWAL & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S AGARWAL & ASSOCIATES | FY 2024 | 07916C |
Shareholding
The shareholding of Apple Formulations Private Limited. is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Apple Formulations Private Limited., buy the company report.
Charges & borrowings
Open charges
₹20 Cr
Satisfied charges
₹9.56 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Aug 2018 | 100205899 | Others | ₹20 Cr | Open | |
| 18 Jul 2020 | 100367547 | Others | ₹23 Lakh | Satisfied | |
| 09 Jun 2018 | 100205897 | Others | ₹5.28 Cr | Satisfied | |
| 08 Nov 2011 | 10374804 | Canara Bank | ₹4.4 Lakh | Satisfied | |
| 07 Jun 2007 | 10061061 | Canara Bank | ₹4 Cr | Satisfied |
To see the full charge records of Apple Formulations Private Limited., buy the company report.
Total charge records: 5 View all charges
Legal cases
Apple Formulations Private Limited. has 46 court cases on record: 20 filed by Apple Formulations Private Limited, 26 filed against it. 29 cases are pending and 17 are disposed.
Total cases
46
Filed by the company
20
Filed against the company
26
Pending
29
Disposed
17
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 29 | 21 | 15 |
| High courts | 17 | 5 | 14 |
Cases on record (5 of 46)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Johnlee Pharmaceuticals Private Limited | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Johnlee Pharmaceuticals Private Limited | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Franco Indian Pharmaceuticals Private Limited | Pending |
| District court, East, Delhi | Criminal case | Filed by the company against M/S Credit Pharmaceuticals Pvt Ltd | Pending |
| District court, East, Delhi | Criminal case | Filed by the company against M/S Crest Pharma Pvt Ltd | Pending |
To see the full case history of Apple Formulations Private Limited., buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Apple Formulations Private Limited. has 3 MSME Form 1 returns on record between 2017 and 2019, listing 537 overdue payments to 42 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 42)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Alpha Plastomers Private Limited | |||
| Ganesh Metal Industries | |||
| Erenco (India) Limited | |||
| an individual supplier | |||
| Omega Printopack Private Limited |
To see the full MSME payment records of Apple Formulations Private Limited., buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Apple Formulations Private Limited. has a workforce of 80 employees on its EPFO records as of Feb 27, 2025, across 1 active EPFO establishment.
Employee count
80
Active EPFO establishments
1
Employee growth
-1.23%
GST
Apple Formulations Private Limited has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAFCA7557E1ZR | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Apple Formulations Private Limited., buy the company report.
Recent activity
Apple Formulations Private Limited. has 8 board changes on record since 2006: 4 appointments and 4 cessations. The latest: Ram Darash Dwivedi was appointed as Director on 08 May 2023.
AGM
Apple Formulations Private Limited. last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Apple Formulations Private Limited. has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others of Rs. 2,000.00 Lakh registered on 08 Aug 2018 with Charge ID 100205899 was modified on 22 Jan 2025.
Appointed
Ram Darash Dwivedi was appointed as Director.
Charges
A charge registered on 18 Jul 2020 via Charge ID 100367547 with Others was fully satisfied on 04 May 2023.
Charges
A charge registered on 09 Jun 2018 via Charge ID 100205897 with Others was fully satisfied on 04 May 2023.
Charges
A charge with Others amounted to Rs. 23.00 Lakh with Charge ID 100367547 was registered on 18 Jul 2020.
Ceased
Binod Kumar Jha ceased to be Additional Director.
Appointed
Binod Kumar Jha was appointed as Director.
Charges
A charge with Others of Rs. 528.20 Lakh registered on 09 Jun 2018 with Charge ID 100205897 was modified on 31 Dec 2018.
Charges
A charge with Others amounted to Rs. 2,000.00 Lakh with Charge ID 100205899 was registered on 08 Aug 2018.
Charges
A charge registered on 07 Jun 2007 via Charge ID 10061061 with Canara Bank was fully satisfied on 28 Jul 2018.
11 earlier events are in the company report.
Frequently asked questions
Apple Formulations Private Limited is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 May 2006 (20+ years old) and is registered under CIN U24121DL2006PTC148648.
Apple Formulations Private Limited has 4 current directors:
- Rahul Khaitan - Director
- Naveen Khaitan - Director
- Binod Kumar Jha - Director
- Ram Darash Dwivedi - Director
The latest financial statements of Apple Formulations Private Limited on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Apple Formulations Private Limited is 05AAFCA7557E1ZR, registered in Uttarakhand. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Apple Formulations Private Limited is U24121DL2006PTC148648. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apple Formulations Private Limited has 46 court cases on record: 20 filed by the company and 26 filed against it. 29 are pending. Most are in the district courts.
Apple Formulations Private Limited was incorporated on 06 May 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Apple Formulations Private Limited by revenue are Socomed Pharma Private Limited, Seagull Pharmaceuticals Pvt Ltd, Stadmed Pvt Ltd, Shree Ganesh Remedies Limited, Unicure Remedies Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ram Darash Dwivedi was appointed as Director on 08 May 2023. Binod Kumar Jha ceased to be Additional Director on 30 Sep 2019. Binod Kumar Jha was appointed as Director on 09 Jan 2019. Apple Formulations Private Limited has 8 board changes on record in total.
Yes, Apple Formulations Private Limited is registered as a medium enterprise under Udyam registration (number: UDYAM-UK-06-0002925).
Apple Formulations Private Limited has 3 MSME Form 1 returns on record between 2017 and 2019, listing 537 overdue payments to 42 micro and small suppliers. The latest return was filed on 31 May 2019.
Apple Formulations Private Limited can be reached through the website appleformulations.com. Its registered office is in Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages